ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years
Kathryn M. Muilenburg
Matched on ORCID iD 0000-0003-1946-6188; OpenAlex author ID A5032008913. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 3
- MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16203439↗
- Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216150↗
- Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.2c00203↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aaron M. Mohs · 3 shared papers, 2022–2024 · strength 0.55
- Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
- Paper Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer. DOI 10.1016/j.canlet.2023.216150↗
- Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
- Mark A. Carlson · 3 shared papers, 2022–2024 · strength 0.55
- Paper MUC16 Retention after Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16203439↗
- Paper Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer. DOI 10.1016/j.canlet.2023.216150↗
- Paper Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expr… DOI 10.1021/acs.molpharmaceut.2c00203↗
- Geoffrey A. Talmon · 2 shared papers, 2022–2024 · strength 0.37
- Madeline T. Olson · 2 shared papers, 2022–2024 · strength 0.37
- Michael Anthony Hollingsworth · 2 shared papers, 2022–2023 · strength 0.34
- Michael Bouvet · 1 shared paper, 2023 · strength 0.18
- Surinder K. Batra · 1 shared paper, 2023 · strength 0.18
- Prakash Radhakrishnan · 1 shared paper, 2023 · strength 0.18
- Eric N. Aguilar · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.